Halozyme Therapeutics Inc $7.57

up +0.02


17/4/2014 08:10 PM  |  NASDAQ : HALO  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get HALO Trend Analysis - it has outperformed the S&P 500 by 12%

Partner Headlines

  1. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  2. Morning Market Movers

    Benzinga
  3. Benzinga's Top #PreMarket Gainers

    Benzinga
  4. Benzinga's Top Initiations

    Benzinga
  5. Markets Falling? Get Your Defense Ready

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. Benzinga's Top #PreMarket Losers

    Benzinga
  8. UPDATE: Halozyme Reports Clinical Hold of PEGPH20 Pancreatic Cancer Trial ...

    Benzinga
  9. Biotechs Struggling To Find A Bottom

    Benzinga
  10. Halozyme Announces Preclinical Data Presentations At The Association Of ...

    Benzinga
  11. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  12. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat ...

    Benzinga
  13. Halozyme Shares Plummet as Concerns Halt Trial

    FoxBusiness
  14. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga
  15. Benzinga's Top #PreMarket Losers

    Benzinga
  16. UPDATE: Halozyme Announces Temporary Halt of Phase 2 Trial Enrollment

    Benzinga
  17. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 ...

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Mid-Afternoon Market Update: Markets Take a Sharp Dip to the Downside, ...

    Benzinga
  20. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  21. UPDATE: Halozyme Spikes Higher on Positive CNBC Comments

    Benzinga
  22. Microsoft's First Xbox TV Series Slated For 1H 2014

    Benzinga
  23. Hottest Game Systems For Christmas: PlayStation 4 vs. Xbox One vs. Wii ...

    Benzinga
  24. Halozyme Receives Milestone Payment of $10M from Roche Following Commercial ...

    Benzinga
  25. Coming Soon: Microsoft Cortana vs. Apple Siri (AAPL, MSFT)

    Benzinga
  26. Halozyme Announces Roche Receives Marketing Authorization for Herceptin ...

    Benzinga
  27. Benzinga Market Wrap for Thursday, August 1: Record Highs!

    Benzinga
  28. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
  29. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
  30. Mid-Day Market Update: Yelp Surges On Narrower Loss, SunPower Shares Decline

    Benzinga
  31. ViroPharma Kills Halozyme Combo Trial; Stocks Fall

    IBD
  32. Mid-Morning Market Update: Markets Rally, Procter & Gamble Earnings Top ...

    Benzinga
  33. Halozyme Issued Update on ViroPharma Phase 2 Trial of C1 Esterase Inhibitor ...

    Benzinga
  34. Benzinga's Top Pre-Market Losers

    Benzinga
  35. Hollywood Hopes There's Still Money in Video Game-Themed Movies

    Benzinga
  36. UPDATE: BMO Capital Markets Reiterates Outperform Rating, Lowers PT on ...

    Benzinga
  37. Jefferies Reiterates Underperform Rating, $4 PT on Halozyme Therapeutics

    Benzinga
  38. Mid-Afternoon Market Update: Herbalife Rises Above Ackman's Top, SunPower ...

    Benzinga
  39. UPDATE: BMO Capital Markets Upgrades Halozyme Therapeutics to Outperform, ...

    Benzinga
  40. The Story Behind Little Halozyme's Seemingly Exciting Hookup With Pfizer

    YCharts
  41. Halozyme Soars After Announcing Deal With Pfizer

    Benzinga
  42. Benzinga's Top Pre-Market Gainers

    Benzinga
  43. Halozyme Therapeutics, Pfizer Collaborate to Develop And Commercialize ...

    Benzinga
  44. Halozyme Announces Roche Filing to European Medicines Agency Triggers $4M ...

    Benzinga
  45. Halozyme Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus
  46. Analyst Upgrades: Halozyme Therapeutics, Zillow, and Celgene

    SchaeffersResearch
  47. Benzinga's M&A Chatter for Wednesday September 26, 2012

    Benzinga
  48. ViroPharma up, FDA lifts ban

    IBD
  49. Benzinga Mid-Afternoon Market Update

    Benzinga
  50. Benzinga Mid-Day Market Update

    Benzinga
Trading Center